14 unknown. 14 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Unknown 14 |
Follow Interferon-alpha: new trials by email Literature Review of Interferon-alpha trials Research Report on Interferon-alpha
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression interferon-alpha (IFN-alpha) - Hepatocellular Carcinoma | Phase 3 | Unknown | Fudan University | 296 | 2012-08-01 | 2018-06-01 |
| Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer BCG solution, recombinant interferon alfa, epirubicin hydrochloride - Bladder Cancer | Phase 3 | Unknown | Cancer Research Campaign Clinical Trials Centre | 242 | 2009-10-01 | 2013-08-12 |
| Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL Rituximab, Cyclophosphamide, Doxorubicin - Lymphoma, Mantle-Cell | Phase 3 | Unknown | European Mantle Cell Lymphoma Network | 570 | 2004-01-14 | 2017-03-07 |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma filgrastim, recombinant interferon alfa, cyclophosphamide - Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Unknown | Commissie Voor Klinisch Toegepast Onderzoek | 450 | 2001-03-01 | 2013-09-17 |
| Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma filgrastim, recombinant interferon alfa, carmustine - Lymphoma | Phase 3 | Unknown | German Low Grade Lymphoma Study Group | 2000-12-01 | 2013-09-17 | |
| Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia filgrastim, recombinant interferon alfa, busulfan - Leukemia | Phase 3 | Unknown | III. Medizinische Klinik Mannheim | 1000 | 1997-07-01 | 2013-12-18 |
| High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma recombinant interferon alfa - Melanoma (Skin) | Phase 3 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 1000 | 1996-04-01 | 2011-11-16 |
| Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma Detox-B adjuvant, recombinant interferon alfa - Melanoma (Skin) | Phase 3 | Unknown | GlaxoSmithKline | 300 | 1996-01-01 | 2014-01-06 |
| Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma recombinant interferon alfa - Lymphoma | Phase 3 | Unknown | Lymphoma Study Association | 360 | 1995-10-01 | 2013-08-07 |
| Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia recombinant interferon alfa, cytarabine, hydroxyurea - Leukemia | Phase 3 | Unknown | Medical Research Council | 800 | 1995-04-01 | 2013-12-19 |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia recombinant interferon alfa, busulfan, cytarabine - Leukemia | Phase 3 | Unknown | German CML Study Group | 750 | 1995-01-01 | 2013-08-02 |
| Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma filgrastim, recombinant interferon alfa, sargramostim - Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Unknown | Medical Research Council | 750 | 1994-09-01 | 2013-12-19 |
| Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma recombinant interferon alfa, chlorambucil, dexamethasone - Lymphoma | Phase 3 | Unknown | Scotland and Newcastle Lymphoma Group | 200 | 1993-11-01 | 2013-09-17 |
| Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer recombinant interferon alfa, fluorouracil, leucovorin calcium - Colorectal Cancer | Phase 3 | Unknown | European Institute of Oncology | 1050 | 1991-11-01 | 2013-09-20 |
Leukemia (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3) · Leukemia, Myeloid, Chronic-Phase (3) · Lymphoma (3) · Lymphoma, Mantle-Cell (3) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Melanoma (2) · Multiple Myeloma (2) · Neoplasms, Plasma Cell (2) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1)
Medical Research Council (2) · Cancer Research Campaign Clinical Trials Centre (1) · Commissie Voor Klinisch Toegepast Onderzoek (1) · European Institute of Oncology (1) · European Mantle Cell Lymphoma Network (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Fudan University (1) · German CML Study Group (1) · German Low Grade Lymphoma Study Group (1) · GlaxoSmithKline (1) · III. Medizinische Klinik Mannheim (1) · Lymphoma Study Association (1) · Scotland and Newcastle Lymphoma Group (1)
United Kingdom (6) · Germany (4) · Italy (4) · Belgium (3) · France (3) · Netherlands (3) · Poland (3) · Czechia (2) · Spain (2) · Switzerland (2) · Austria (1) · Bulgaria (1) · China (1) · Croatia (1) · Denmark (1)
Ruediger Hehlmann, MD (2) · Achiel Van Hoof, MD (1) · Alessandro Levis, MD (1) · Alexander M. M. Eggermont, MD, PhD (1) · Bertrand Coiffier, MD (1) · Francesco Tonelli, MD (1) · H. Lokhorst, MD, PhD (1) · Hanneke C. Kluin-Nelemans, PhD (1) · J. A. Child, MD (1) · J. C. Kluin-Nelemans, MD, PhD (1) · Jia Fan, MD, PHD (1) · John Kelly, MD (1) · Kenneth B. Von Eschen, PhD (1) · Martin Dreyling, PhD (1) · Patricia Shepherd, MD (1)
PMID 15010373, PMID 16198768, PMID 18077791, PMID 18166796, PMID 19880501, PMID 20032498, PMID 21087856, PMID 21546857, PMID 22442350, PMID 22873532, PMID 24687837, PMID 30274699, PMID 31804876, PMID 37992261